Abiopharma

Lantern Pharma to Report Second Quarter 2026 Operating & Financial Results on August 14th, 2026 at 9:00 a.m. ET

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

bioAffinity Technologies Reports Second Quarter 2026 Results and Continued Strong Commercial Momentum for CyPath® Lung

YXT.com to Announce Financial Results for the First Six Months of 2026 on August 13, 2026

ClearBridge Energy Midstream Opportunity Fund Inc. Announces Unaudited Balance Sheet Information as of July 31, 2026

Viking Takes Delivery of Newest Egypt Ship

TOYO Solar Welcomes President Trumps Section 232 Action to Accelerate American Solar Manufacturing

JCP&L Rate Proposal Delays Bill Impact for Residential Customers Until 2028 While Supporting Reliability Investments

AMETEK Declares Quarterly Dividend

SABINE ROYALTY TRUST ANNOUNCES MONTHLY CASH DISTRIBUTION FOR AUGUST 2026